for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Roche Announces Monthly and Yearly Rozlytrek Treatment Costs In U.S.

Aug 16 (Reuters) - Roche Holding AG:

* ROCHE - MONTHLY COST OF ROZLYTREK FOR ADULTS WITH ROS1-POSITIVE METASTATIC NSCLC & FOR ADULTS WITH NTRK FUSION-POSITIVE SOLID TUMOURS IS ABOUT $17,050

* ROCHE - ANNUAL COST OF TREATMENT WITH ROZLYTREK IS ABOUT $204,560 Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up